Vontobel Holding’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,750
| Closed | -$324K | – | 1113 |
|
|
2023
Q3 | $324K | Hold |
6,750
| – | – | ﹤0.01% | 880 |
|
|
2023
Q2 | $351K | Hold |
6,750
| – | – | ﹤0.01% | 889 |
|
|
2023
Q1 | $366K | Buy |
6,750
+1,000
| +17% | +$54.2K | ﹤0.01% | 846 |
|
|
2022
Q4 | $332K | Buy |
+5,750
| New | +$332K | ﹤0.01% | 868 |
|
|
2022
Q2 | – | Sell |
-3,321
| Closed | -$206K | – | 1026 |
|
|
2022
Q1 | $206K | Buy |
3,321
+344
| +12% | +$21.3K | ﹤0.01% | 997 |
|
|
2021
Q4 | $241K | Buy |
2,977
+266
| +10% | +$21.5K | ﹤0.01% | 965 |
|
|
2021
Q3 | $257K | Sell |
2,711
-2,729
| -50% | -$259K | ﹤0.01% | 977 |
|
|
2021
Q2 | $536K | Buy |
5,440
+4,425
| +436% | +$436K | ﹤0.01% | 738 |
|
|
2021
Q1 | $85K | Buy |
+1,015
| New | +$85K | ﹤0.01% | 955 |
|